Edition:
United States

People: Accelerate Diagnostics Inc (AXDX.O)

AXDX.O on Consolidated Issue listed on NASDAQ Capital Market

28.25USD
26 May 2017
Change (% chg)

$-0.45 (-1.57%)
Prev Close
$28.70
Open
$28.55
Day's High
$28.85
Day's Low
$28.10
Volume
107,794
Avg. Vol
305,391
52-wk High
$29.95
52-wk Low
$11.85

Reichling, Steve 

Mr. Steve Reichling is Chief Financial Officer of Accelerate Diagnostics Inc. since September 10, 2012. Prior to joining the Company, Mr. Reichling served as general manager of Spring Bioscience Corp. a subsidiary of Roche Tissue Diagnostics. From January 2003 to December 2009, Mr. Reichling held various finance, accounting and operations leadership roles at Roche Tissue Diagnostics and Ventana Medical Systems, Inc. including director of finance and operations, manager of business development finance, and head of Internal Audit and Sarbanes Oxley Compliance. From October 2002 to January 2003, Mr. Reichling was an auditor at Ernst & Young LLP. Mr. Reichling received his B.A. in accounting and entrepreneurship from the University of Arizona and is a Certified Public Accountant.

Basic Compensation

Total Annual Compensation, USD 230,385
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 308,714
Fiscal Year Total, USD 539,099

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --